Submission of requests for joint scientific consultations
Article 3
1. Any time during the request period published pursuant to Article 17(3) of Regulation (EU) 2021/2282, the health technology developer may submit a request for a joint scientific consultation on the medicinal product through the IT platform referred to in Article 30 of that Regulation (‘the HTA IT platform’). The request shall follow the template established by the Coordination Group pursuant to Article 21, point (a), of Regulation (EU) 2021/2282. 2. When submitting the request referred to in paragraph 1, the health technology developer shall indicate whether, in parallel, it is requesting scientific advice from the European Medicines Agency. 3. By the end of a request period, the Commission acting as secretariat of the Coordination Group (‘HTA secretariat’) shall make available through the HTA IT platform the requests for joint scientific consultation on medicinal products complying with the requirements in paragraph 1, second subparagraph, to the subgroup on joint scientific consultations of the Coordination Group (‘JSC Subgroup’) and indicate for which of those requests scientific advice will be sought in parallel.